Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FBIOX vs RYOIX overlap: 53% of top holdings shared

Bottom line

How much do FBIOX and RYOIX overlap?

53% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 37.8% of FBIOX's assets and 36.7% of RYOIX's. They share a meaningful core but differ in the rest of the portfolio.

FBIOX holds far more positions (215 vs 74), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

FBIOXRYOIX
Weight overlap (top 25)53%
Shared holdings13
Weight in shared holdings37.8%36.7%
Total positions21574
Expense ratio0.62%1.38%
Holdings as ofMay 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Holdings FBIOX and RYOIX have in common

Holding% of FBIOX% of RYOIXOverlap
Abbvie Inc9.22%8.17%8.17%
Amgen Inc6.53%5.05%5.05%
Gilead Sciences Inc4.82%4.49%4.49%
Alnylam Pharmaceuticals Inc2.93%2.36%2.36%
Insmed Inc2.25%1.79%1.79%
Argenx Se2.25%1.48%1.48%
Revolution Medicines Inc2.02%2.48%2.02%
Jazz Pharmaceuticals Plc1.84%1.42%1.42%
Natera Inc1.41%2.12%1.41%
Moderna Inc1.28%2.15%1.28%
Biogen Inc1.26%2.13%1.26%
Roivant Sciences Ltd1.13%1.66%1.13%
Bridgebio Pharma Inc0.89%1.38%0.89%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FBIOX

  1. Krystal Biotech Inc — 10.58%
  2. Fidelity Revere Street Trust — 3.35%
  3. Praxis Precision Medicines Inc. — 2.47%
  4. Ascendis Pharma A/s — 2.04%
  5. Ucb Sa — 2.00%
  6. Scholar Rock Holding Corp — 1.55%
  7. Axsome Therapeutics Inc — 1.28%
  8. Protagonist Therapeutics Inc — 1.15%
  9. Cogent Biosciences Inc — 1.07%
  10. Tango Therapeutics Inc — 0.98%
  11. Celcuity Inc — 0.95%
  12. Madrigal Pharmaceuticals Inc — 0.93%

Only in RYOIX

  1. Vertex Pharmaceuticals Inc — 4.32%
  2. Regeneron Pharmaceuticals Inc — 2.93%
  3. Beone Medicines Ltd — 2.17%
  4. Royalty Pharma Plc — 2.01%
  5. Illumina Inc — 1.94%
  6. United Therapeutics Corp — 1.72%
  7. Guardant Health Inc — 1.72%
  8. Incyte Corp — 1.62%
  9. Viatris Inc — 1.55%
  10. Neurocrine Biosciences Inc — 1.52%
  11. Ionis Pharmaceuticals Inc — 1.35%
  12. Cytokinetics Inc — 1.35%

Asset mix

Asset typeFBIOXRYOIX
Stocks99.0%99.6%
Cash & short-term funds3.5%0.6%
Preferred stock0.9%—
Repurchase agreements—0.6%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Country mix

CountryFBIOXRYOIX
US88.5%85.8%
CH1.1%3.3%
GB0.8%3.2%
NL2.9%1.5%
IE2.0%2.7%
DK2.6%0.9%
BE2.0%—
BM1.1%1.7%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do FBIOX and RYOIX overlap?
About 53% by weight. 13 securities appear in both funds' top 25 holdings; they make up 37.8% of FBIOX's assets and 36.7% of RYOIX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do FBIOX and RYOIX have in common?
The largest shared holdings are Abbvie Inc, Amgen Inc, Gilead Sciences Inc, Alnylam Pharmaceuticals Inc, Revolution Medicines Inc.
Should I own both FBIOX and RYOIX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, FBIOX or RYOIX?
FBIOX is broader, with 215 positions versus 74 for RYOIX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.